Skip to main content
Top
Published in: Abdominal Radiology 11/2021

01-11-2021 | Kidneys, Ureters, Bladder, Retroperitoneum

Robustness and performance of radiomic features in diagnosing cystic renal masses

Authors: Arda Könik, Nityanand Miskin, Yang Guo, Atul B. Shinagare, Lei Qin

Published in: Abdominal Radiology | Issue 11/2021

Login to get access

Abstract

Purpose

We study the inter-reader variability in manual delineation of cystic renal masses (CRMs) presented in computerized tomography (CT) images and its effect on the classification performance of a machine learning algorithm in distinguishing benign from potentially malignant CRMs. In addition, we assessed whether the inclusion of higher-order robust radiomic features improves the classification performance over the use of first-order features.

Methods

230 CRMs were independently delineated by two radiologists. Through a combination of random fluctuations, dilation, and erosion operations over the original region of interests (ROIs), we generated four additional sets of synthetic ROIs to capture the inter-reader variability realistically, as confirmed by dice coefficient measurements and visual assessment. We then identified the robust features based on the intra-class coefficient (ICC > 0.85) across these datasets. We applied a tenfold stratified cross-validation (CV) to train and test the performance of the random forest model for the classification of CRMs into benign and potentially malignant.

Results

The mean area under the curve (AUC), sensitivity, specificity, positive predictive value, and negative predictive value were 0.87, 0.82, 0.90, 0.85, and 0.93, respectively. With the usage of first-order features alone, the corresponding values were nearly identical.

Conclusion

AUC ranged for the robust and uncorrelated features from 0.83 ± 0.09 to 0.93 ± 0.04 and for the first-order features from 0.84 ± 0.09 to 0.91 ± 0.04. Our study indicates that the first-order features alone are sufficient for the classification of CRMs, and that inclusion of higher-order features does not necessarily improve performance.
Literature
1.
go back to reference L. L. Berland et al., "Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee," J Am Coll Radiol, vol. 7, no. 10, pp. 754-73, Oct 2010.CrossRef L. L. Berland et al., "Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee," J Am Coll Radiol, vol. 7, no. 10, pp. 754-73, Oct 2010.CrossRef
2.
go back to reference S. G. Silverman et al., "Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment," Radiology, vol. 292, no. 2, pp. 475-488, Aug 2019.CrossRef S. G. Silverman et al., "Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment," Radiology, vol. 292, no. 2, pp. 475-488, Aug 2019.CrossRef
3.
go back to reference N. M. Hindman, E. M. Hecht, and M. A. Bosniak, "Follow-up for Bosniak category 2F cystic renal lesions," Radiology, vol. 272, no. 3, pp. 757-66, Sep 2014.CrossRef N. M. Hindman, E. M. Hecht, and M. A. Bosniak, "Follow-up for Bosniak category 2F cystic renal lesions," Radiology, vol. 272, no. 3, pp. 757-66, Sep 2014.CrossRef
4.
go back to reference N. M. Hindman, "Cystic renal masses," Abdom Radiol (NY), vol. 41, no. 6, pp. 1020-34, Jun 2016.CrossRef N. M. Hindman, "Cystic renal masses," Abdom Radiol (NY), vol. 41, no. 6, pp. 1020-34, Jun 2016.CrossRef
5.
go back to reference S. G. Silverman, Y. U. Gan, K. J. Mortele, K. Tuncali, and E. S. Cibas, "Renal masses in the adult patient: the role of percutaneous biopsy," Radiology, vol. 240, no. 1, pp. 6-22, Jul 2006.CrossRef S. G. Silverman, Y. U. Gan, K. J. Mortele, K. Tuncali, and E. S. Cibas, "Renal masses in the adult patient: the role of percutaneous biopsy," Radiology, vol. 240, no. 1, pp. 6-22, Jul 2006.CrossRef
6.
go back to reference B. Kocak, E. S. Durmaz, E. Ates, and O. Kilickesmez, "Radiomics with artificial intelligence: a practical guide for beginners," Diagn Interv Radiol, vol. 25, no. 6, pp. 485-495, Nov 2019.CrossRef B. Kocak, E. S. Durmaz, E. Ates, and O. Kilickesmez, "Radiomics with artificial intelligence: a practical guide for beginners," Diagn Interv Radiol, vol. 25, no. 6, pp. 485-495, Nov 2019.CrossRef
7.
go back to reference M. Avanzo et al., "Machine and deep learning methods for radiomics," Med Phys, vol. 47, no. 5, pp. e185-e202, Jun 2020.CrossRef M. Avanzo et al., "Machine and deep learning methods for radiomics," Med Phys, vol. 47, no. 5, pp. e185-e202, Jun 2020.CrossRef
8.
go back to reference R. Suarez-Ibarrola, M. Basulto-Martinez, A. Heinze, C. Gratzke, and A. Miernik, "Radiomics Applications in Renal Tumor Assessment: A Comprehensive Review of the Literature," Cancers (Basel), vol. 12, no. 6, May 28 2020. R. Suarez-Ibarrola, M. Basulto-Martinez, A. Heinze, C. Gratzke, and A. Miernik, "Radiomics Applications in Renal Tumor Assessment: A Comprehensive Review of the Literature," Cancers (Basel), vol. 12, no. 6, May 28 2020.
9.
go back to reference N. Miskin et al., "Stratification of cystic renal masses into benign and potentially malignant: applying machine learning to the bosniak classification," Abdominal Radiology, 2020. N. Miskin et al., "Stratification of cystic renal masses into benign and potentially malignant: applying machine learning to the bosniak classification," Abdominal Radiology, 2020.
10.
go back to reference J. J. Foy, K. R. Robinson, H. Li, M. L. Giger, H. Al-Hallaq, and S. G. Armato, 3rd, "Variation in algorithm implementation across radiomics software," Journal of medical imaging, vol. 5, no. 4, p. 044505, Oct 2018. J. J. Foy, K. R. Robinson, H. Li, M. L. Giger, H. Al-Hallaq, and S. G. Armato, 3rd, "Variation in algorithm implementation across radiomics software," Journal of medical imaging, vol. 5, no. 4, p. 044505, Oct 2018.
11.
go back to reference M. E. Mayerhoefer et al., "Introduction to Radiomics," J Nucl Med, vol. 61, no. 4, pp. 488-495, Apr 2020.CrossRef M. E. Mayerhoefer et al., "Introduction to Radiomics," J Nucl Med, vol. 61, no. 4, pp. 488-495, Apr 2020.CrossRef
12.
go back to reference F. Rizzetto et al., "Impact of inter-reader contouring variability on textural radiomics of colorectal liver metastases," Eur Radiol Exp, vol. 4, no. 1, p. 62, Nov 10 2020. F. Rizzetto et al., "Impact of inter-reader contouring variability on textural radiomics of colorectal liver metastases," Eur Radiol Exp, vol. 4, no. 1, p. 62, Nov 10 2020.
13.
go back to reference X. Zhang et al., "The effects of volume of interest delineation on MRI-based radiomics analysis: evaluation with two disease groups," Cancer Imaging, vol. 19, no. 1, p. 89, Dec 21 2019. X. Zhang et al., "The effects of volume of interest delineation on MRI-based radiomics analysis: evaluation with two disease groups," Cancer Imaging, vol. 19, no. 1, p. 89, Dec 21 2019.
14.
go back to reference M. Pavic et al., "Influence of inter-observer delineation variability on radiomics stability in different tumor sites," Acta Oncol, vol. 57, no. 8, pp. 1070-1074, Aug 2018.CrossRef M. Pavic et al., "Influence of inter-observer delineation variability on radiomics stability in different tumor sites," Acta Oncol, vol. 57, no. 8, pp. 1070-1074, Aug 2018.CrossRef
15.
go back to reference C. Haarburger, G. Muller-Franzes, L. Weninger, C. Kuhl, D. Truhn, and D. Merhof, "Radiomics feature reproducibility under inter-rater variability in segmentations of CT images," Sci Rep, vol. 10, no. 1, p. 12688, Jul 29 2020. C. Haarburger, G. Muller-Franzes, L. Weninger, C. Kuhl, D. Truhn, and D. Merhof, "Radiomics feature reproducibility under inter-rater variability in segmentations of CT images," Sci Rep, vol. 10, no. 1, p. 12688, Jul 29 2020.
16.
go back to reference T. K. Koo and M. Y. Li, "A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research," J Chiropr Med, vol. 15, no. 2, pp. 155-63, Jun 2016.CrossRef T. K. Koo and M. Y. Li, "A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research," J Chiropr Med, vol. 15, no. 2, pp. 155-63, Jun 2016.CrossRef
17.
go back to reference M. Vallieres, C. R. Freeman, S. R. Skamene, and I. El Naqa, "A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities," Phys Med Biol, vol. 60, no. 14, pp. 5471-96, Jul 21 2015.CrossRef M. Vallieres, C. R. Freeman, S. R. Skamene, and I. El Naqa, "A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities," Phys Med Biol, vol. 60, no. 14, pp. 5471-96, Jul 21 2015.CrossRef
18.
go back to reference C. Parmar, P. Grossmann, J. Bussink, P. Lambin, and H. Aerts, "Machine Learning methods for Quantitative Radiomic Biomarkers," Sci Rep, vol. 5, p. 13087, Aug 17 2015. C. Parmar, P. Grossmann, J. Bussink, P. Lambin, and H. Aerts, "Machine Learning methods for Quantitative Radiomic Biomarkers," Sci Rep, vol. 5, p. 13087, Aug 17 2015.
19.
go back to reference J. Uhlig et al., "Discriminating malignant and benign clinical T1 renal masses on computed tomography: A pragmatic radiomics and machine learning approach," Medicine (Baltimore), vol. 99, no. 16, p. e19725, Apr 2020. J. Uhlig et al., "Discriminating malignant and benign clinical T1 renal masses on computed tomography: A pragmatic radiomics and machine learning approach," Medicine (Baltimore), vol. 99, no. 16, p. e19725, Apr 2020.
20.
go back to reference C. Erdim et al., "Prediction of Benign and Malignant Solid Renal Masses: Machine Learning-Based CT Texture Analysis," Acad Radiol, vol. 27, no. 10, pp. 1422-1429, Oct 2020.CrossRef C. Erdim et al., "Prediction of Benign and Malignant Solid Renal Masses: Machine Learning-Based CT Texture Analysis," Acad Radiol, vol. 27, no. 10, pp. 1422-1429, Oct 2020.CrossRef
21.
go back to reference S. A. Mattonen et al., "Bone Marrow and Tumor Radiomics at (18)F-FDG PET/CT: Impact on Outcome Prediction in Non-Small Cell Lung Cancer," Radiology, vol. 293, no. 2, pp. 451-459, Nov 2019.CrossRef S. A. Mattonen et al., "Bone Marrow and Tumor Radiomics at (18)F-FDG PET/CT: Impact on Outcome Prediction in Non-Small Cell Lung Cancer," Radiology, vol. 293, no. 2, pp. 451-459, Nov 2019.CrossRef
22.
go back to reference R. Liu et al., "Stability analysis of CT radiomic features with respect to segmentation variation in oropharyngeal cancer," Clin Transl Radiat Oncol, vol. 21, pp. 11-18, Mar 2020.CrossRef R. Liu et al., "Stability analysis of CT radiomic features with respect to segmentation variation in oropharyngeal cancer," Clin Transl Radiat Oncol, vol. 21, pp. 11-18, Mar 2020.CrossRef
23.
go back to reference B. Kocak, E. Ates, E. S. Durmaz, M. B. Ulusan, and O. Kilickesmez, "Influence of segmentation margin on machine learning-based high-dimensional quantitative CT texture analysis: a reproducibility study on renal clear cell carcinomas," Eur Radiol, vol. 29, no. 9, pp. 4765-4775, Sep 2019.CrossRef B. Kocak, E. Ates, E. S. Durmaz, M. B. Ulusan, and O. Kilickesmez, "Influence of segmentation margin on machine learning-based high-dimensional quantitative CT texture analysis: a reproducibility study on renal clear cell carcinomas," Eur Radiol, vol. 29, no. 9, pp. 4765-4775, Sep 2019.CrossRef
24.
go back to reference A. Zwanenburg et al., "Assessing robustness of radiomic features by image perturbation," Sci Rep, vol. 9, no. 1, p. 614, Jan 24 2019. A. Zwanenburg et al., "Assessing robustness of radiomic features by image perturbation," Sci Rep, vol. 9, no. 1, p. 614, Jan 24 2019.
25.
go back to reference L. Joskowicz, D. Cohen, N. Caplan, and J. Sosna, "Inter-observer variability of manual contour delineation of structures in CT," Eur Radiol, vol. 29, no. 3, pp. 1391-1399, Mar 2019.CrossRef L. Joskowicz, D. Cohen, N. Caplan, and J. Sosna, "Inter-observer variability of manual contour delineation of structures in CT," Eur Radiol, vol. 29, no. 3, pp. 1391-1399, Mar 2019.CrossRef
26.
go back to reference M. C. F. Cysouw et al., "Machine learning-based analysis of [(18)F]DCFPyL PET radiomics for risk stratification in primary prostate cancer," Eur J Nucl Med Mol Imaging, Jul 31 2020. M. C. F. Cysouw et al., "Machine learning-based analysis of [(18)F]DCFPyL PET radiomics for risk stratification in primary prostate cancer," Eur J Nucl Med Mol Imaging, Jul 31 2020.
27.
go back to reference A. Traverso, L. Wee, A. Dekker, and R. Gillies, "Repeatability and Reproducibility of Radiomic Features: A Systematic Review," Int J Radiat Oncol Biol Phys, vol. 102, no. 4, pp. 1143-1158, Nov 15 2018.CrossRef A. Traverso, L. Wee, A. Dekker, and R. Gillies, "Repeatability and Reproducibility of Radiomic Features: A Systematic Review," Int J Radiat Oncol Biol Phys, vol. 102, no. 4, pp. 1143-1158, Nov 15 2018.CrossRef
28.
go back to reference M. M. Nguyen and I. S. Gill, "Effect of renal cancer size on the prevalence of metastasis at diagnosis and mortality," J Urol, vol. 181, no. 3, pp. 1020–7; discussion 1027, Mar 2009. M. M. Nguyen and I. S. Gill, "Effect of renal cancer size on the prevalence of metastasis at diagnosis and mortality," J Urol, vol. 181, no. 3, pp. 1020–7; discussion 1027, Mar 2009.
29.
go back to reference C. Shen et al., "2D and 3D CT Radiomics Features Prognostic Performance Comparison in Non-Small Cell Lung Cancer," Transl Oncol, vol. 10, no. 6, pp. 886-894, Dec 2017.CrossRef C. Shen et al., "2D and 3D CT Radiomics Features Prognostic Performance Comparison in Non-Small Cell Lung Cancer," Transl Oncol, vol. 10, no. 6, pp. 886-894, Dec 2017.CrossRef
30.
go back to reference L. Meng et al., "2D and 3D CT Radiomic Features Performance Comparison in Characterization of Gastric Cancer: A Multi-center Study," IEEE J Biomed Health Inform, vol. PP, Jun 16 2020. L. Meng et al., "2D and 3D CT Radiomic Features Performance Comparison in Characterization of Gastric Cancer: A Multi-center Study," IEEE J Biomed Health Inform, vol. PP, Jun 16 2020.
31.
go back to reference S. Roy et al., "Optimal co-clinical radiomics: Sensitivity of radiomic features to tumour volume, image noise and resolution in co-clinical T1-weighted and T2-weighted magnetic resonance imaging," EBioMedicine, vol. 59, p. 102963, Sep 2020. S. Roy et al., "Optimal co-clinical radiomics: Sensitivity of radiomic features to tumour volume, image noise and resolution in co-clinical T1-weighted and T2-weighted magnetic resonance imaging," EBioMedicine, vol. 59, p. 102963, Sep 2020.
32.
go back to reference D. Arefan, R. Chai, M. Sun, M. L. Zuley, and S. Wu, "Machine learning prediction of axillary lymph node metastasis in breast cancer: 2D versus 3D radiomic features," Med Phys, vol. 47, no. 12, pp. 6334-6342, Dec 2020.CrossRef D. Arefan, R. Chai, M. Sun, M. L. Zuley, and S. Wu, "Machine learning prediction of axillary lymph node metastasis in breast cancer: 2D versus 3D radiomic features," Med Phys, vol. 47, no. 12, pp. 6334-6342, Dec 2020.CrossRef
Metadata
Title
Robustness and performance of radiomic features in diagnosing cystic renal masses
Authors
Arda Könik
Nityanand Miskin
Yang Guo
Atul B. Shinagare
Lei Qin
Publication date
01-11-2021
Publisher
Springer US
Published in
Abdominal Radiology / Issue 11/2021
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-021-03241-2

Other articles of this Issue 11/2021

Abdominal Radiology 11/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine